Functional role of kallikrein 6 in regulating immune cell survival

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Scarisbrick, Isobel A ^a   Epstein, Benjamin ^a   Cloud, Beth A ^a   Yoon, Hyesook ^a   Wu, Jianmin ^a   Renner, Danielle N ^a   Blaber, Sachiko I ^b   Blaber, Michael ^b   Vandell, Alexander G ^a   Bryson, Alexandra L ^a  

^a MAYO CLINIC   (United States)

^b FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN 6; PROTEIN BCL 2; PROTEINASE ACTIVATED RECEPTOR 1; RECOMBINANT ENZYME; KALLIKREIN; KLK6 PROTEIN, HUMAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; PROTEIN INTERACTION; SPLEEN CELL; T LYMPHOCYTE; ANIMAL; B LYMPHOCYTE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; LYMPHOCYTE; METABOLISM; SIGNAL TRANSDUCTION; SPLEEN;

MURINAE; MUS;

ANIMALS; B-LYMPHOCYTES; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; JURKAT CELLS; KALLIKREINS; LYMPHOCYTES; MICE; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, PAR-1; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES;

EID: 79953127601     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018376     Document Type: Article

References (63)

1. Scarisbrick IA, Blaber SI, Lucchinetti CF, Genain CP, Blaber M, et al. (2002) Activity of a newly identified serine protease in CNS demyelination. Brain 125: 1283-1296.
2. Christophi GP, Isackson PJ, Blaber SI, Blaber M, Rodriguez M, et al. (2004) Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease. J Neurochem 91: 1439-1449.
3. Scarisbrick IA, Blaber SI, Tingling JT, Rodriguez M, Blaber M, et al. (2006) Potential scope of action of tissue kallikreins in CNS immune-mediated disease. J Neuroimmunology 178: 167-176.
4. Scarisbrick IA, Linbo R, Vandell AG, Keegan M, Blaber SI, et al. (2008) Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration. Biol Chem 389: 739-745.
5. Blaber SI, Ciric B, Christophi GP, Bernett MJ, Blaber M, et al. (2004) Targeting kallikrein 6-proteolysis attenuates CNS inflammatory disease. FASEB J 19: 920-922.
6. Bernett MJ, Blaber SI, Scarisbrick IA, Dhanarajan P, Thompson SM, et al. (2002) Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system. J Biol Chem 277: 24562-24570.
7. Blaber SI, Scarisbrick IA, Bernett MJ, Dhanarajan P, Seavy MA, et al. (2002) Enzymatic properties of rat myelencephalon-specific protease. Biochemistry 41: 1165-1173.
8. Angelo PF, Lima AR, Alves FM, Blaber SI, Scarisbrick IA, et al. (2006) Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects. J Biol Chem 281: 3116-3126.
9. Oikonomopoulou K, Hansen KK, Saifeddine M, Tea I, Blaber M, et al. (2006) Proteinase-activated receptors, targets for kallikrein signaling. J Biol Chem 281: 32095-32112.
10. Oikonomopoulou K, Hansen KK, Saifeddine M, Vergnolle N, Tea I, et al. (2006) Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs). Biol Chem 387: 817-824.
11. Vandell AG, Larson N, Laxmikanthan G, Panos M, Blaber SI, et al. (2008) Protease Activated Receptor Dependent and Independent Signaling by Kallikreins 1 and 6 in CNS Neuron and Astroglial Cell Lines. J Neurochem 107: 855-870.
12. Shpacovitch V, Feld M, Hollenberg MD, Luger TA, Steinhoff M, (2008) Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol 83: 1309-1322.
13. Malamud V, Vaaknin A, Abramsky O, Mor M, Burgess LE, et al. (2003) Tryptase activates peripheral blood mononuclear cells causing synthesis and release of TNF-a, IL-6 and IL-1B: possible relevance to multiple sclerosis. J Neuroimmunology 138: 115-122.
14. Colongnato R, Slupsky JR, Jendrach M, Burysek L, Syrovets T, et al. (2003) Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood 102: 2645-2652.
15. Fields RC, Schoenecker JG, Hart JP, Hoffman MR, Pizzo SV, et al. (2003) Protease-activated receptor-2 signaling triggers dendritic cell development. Am J Path 162: 1817-1822.
16. Li T, Want H, He S, (2006) Induction of IL-6 release from monocytes by serine proteinases and its potential mechanisms. Scand J Immunol 64: 10-16.
17. Altieri DC, Stamnes SJ, (1994) Protease-dependent T cell activation: ligation of effector cell protease receptor-1 (EPR-1) stimulates lymphocyte proliferation. Cell Immunol 155: 371-383.
18. Wee JL, Chionh YT, Ng GZ, Harbour SN, Allison C, et al. (2009) Protease Activated Receptor-1 down-regulates the murine inflammatory and humoral response to Helicobacter pylori. Gastroenterology.
19. Vergnolle N, Cellars L, Mencarelli A, Rizzo G, Swaminathan S, et al. (2004) A role for proteinase-activated receptor-1 in inflammatory bowel diseases. J Clin Invest 114: 1444-1456.
20. Cunningham MA, Rondeau E, Chen X, Coughlin SR, Holdsworth SR, et al. (2000) Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191: 455-462.
21. Yang YH, Hall P, Little CB, Fosang AJ, Milenkovski G, et al. (2005) Reduction of arthritis severity in protease-activated receptor-deficient mice. Arthritis Rheum 52: 1325-1332.
22. Kouzaki H, O'Grady SM, Lawrence CB, Kita H, (2009) Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol 183: 1427-1434.
23. Ferrell WR, Lockhart JC, Kelso EB, Dunning L, Plevin R, et al. (2003) Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest 111: 35-41.
24. Kawagoe J, Takizawa T, Matsumoto J, Tamiya M, Meek SE, et al. (2002) Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear. Jpn J Pharmacol 88: 77-84.
25. Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, et al. (2006) Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 203: 425-435.
26. Laxmikanthan G, Blaber SI, Bernett MJ, Scarisbrick IA, Juliano MA, et al. (2005) 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding. Proteins 58: 802-814.
27. Song Q, Chao J, Chao L, (1996) High level of circulating human tissue kallikrein induces hypotension in a transgenic mouse model. Clin Exp Hypertens 18: 975-993.
28. Diamandis EP, Yousef GM, Soosaipillai AR, Bunting P, (2000) Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin Biochem 33: 579-583.
29. Zarghooni M, Soosaipillai A, Grass L, Scorilas A, Mirazimi N, et al. (2002) Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients. Clinical Biochemistry 35: 225-231.
30. Borgono CA, Miacovos MP, Diamandis EP, (2004) Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2: 257-280.
31. Brenner D, Mak TW, (2009) Mitochondrial cell death effectors. Curr Opin Cell Biol 21: 871-877.
32. Cohen GM, (1997) Caspases: the executioners of apoptosis. Biochem J 326 (Pt 1): 1-16.
33. Hildeman DA, Zhu Y, Mitchell TC, Bouillet P, Strasser A, et al. (2002) Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16: 759-767.
34. Chae HJ, Kang JS, Byun JO, Han KS, Kim DU, et al. (2000) Molecular mechanism of staurosporine-induced apoptosis in osteoblasts. Pharmacol Res 42: 373-381.
35. Zhang XD, Gillespie SK, Hersey P, (2004) Staurosporine induces apoptosis of melanoma by both caspase-dependent and-independent apoptotic pathways. Mol Cancer Ther 3: 187-197.
36. Brown DG, Sun XM, Cohen GM, (1993) Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J Biol Chem 268: 3037-3039.
37. Zacharchuk CM, Mercep M, Chakraborti PK, Simons SS Jr, Ashwell JD, (1990) Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. J Immunol 145: 4037-4045.
38. Ashwell JD, Cunningham RE, Noguchi PD, Hernandez D, (1987) Cell growth cycle block of T cell hybridomas upon activation with antigen. J Exp Med 165: 173-194.
39. Ferraro C, Quemeneur L, Fournel S, Prigent AF, Revillard JP, et al. (2000) The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes. Cell Death Differ 7: 197-206.
40. Lyons AB, Parish CR, (1994) Determination of lymphocyte division by flow cytometry. J Immunol Methods 171: 131-137.
41. Zilman A, Ganusov VV, Perelson AS, (2010) Stochastic models of lymphocyte proliferation and death. PLoS One 5.
42. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, et al. (1997) Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 90: 935-943.
43. Kaufmann S, Desnoyers S, Ottaviano Y, Davidson N, Poirier G, (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976-3985.
44. Lei K, Davis RJ, (2003) JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A 100: 2432-2437.
45. Chen D, Zhou Q, (2004) Caspase cleavage of BimEL triggers a positive feedback amplification of apoptotic signaling. Proc Natl Acad Sci U S A 101: 1235-1240.
46. Scarisbrick IA, Sabharwal P, Cruz H, Larsen N, Vandell A, et al. (2006) Dynamic role of kallikrein 6 in traumatic spinal cord injury. Eur J Neuroscience 24: 1457-1469.
47. Coughlin SR, Camerer E, (2003) PARticipation in inflammation. J Clin Invest 111: 25-27.
48. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, et al. (2005) Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26: 1-43.
49. Tantivejkul K, Loberg RD, Mawocha SC, Day LL, John LS, et al. (2005) PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism. J Cell Biochem 96: 641-652.
50. Yang E, Boire A, Agarwal A, Nguyen N, O'Callaghan K, et al. (2009) Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis. Cancer Res 69: 6223-6231.
51. Chalmers CJ, Balmanno K, Hadfield K, Ley R, Cook SJ, (2003) Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1. Biochem J 375: 99-109.
52. Wang Y, Luo W, Stricker R, Reiser G, (2006) Protease-activated receptor-1 protects rat astrocytes from apoptotic cell death via JNK-mediated release of the chemokine GRO/CINC-1. J Neurochem 98: 1046-1060.
53. Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, et al. (2008) Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451: 1076-1081.
54. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, et al. (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735-1738.
55. Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, et al. (2002) BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415: 922-926.
56. Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, et al. (2003) Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med 198: 1119-1126.
57. Pellegrini M, Belz G, Bouillet P, Strasser A, (2003) Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc Natl Acad Sci U S A 100: 14175-14180.
58. Scarisbrick IA, Towner MD, Isackson PJ, (1997) Nervous system specific expression of a novel serine protease: regulation in the adult rat spinal cord by excitotoxic injury. J Neurosci 17: 8156-8168.
59. Clements J, Hooper J, Dong Y, Harvey T, (2001) The expanded human kallikrein (KLK) gene family: genomic organization, tissue-specific expression and potential functions. Biol Chem 382: 5-14.
60. Anisowicz A, Sotiropoulou G, Stenman G, Mok SC, Sager R, (1996) A novel protease homolog differentially expressed in breast and ovarian cancer. Mol Med 2: 624-636.
61. Mitsui S, Okui A, Uemura H, Mizuno T, Yamada T, et al. (2002) Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease. Ann N Y Acad Sci 977: 216-223.
62. Ruckert F, Hennig M, Petraki CD, Wehrum D, Distler M, et al. (2008) Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma. Br J Cancer 99: 1484-1492.
63. White NM, Mathews M, Yousef GM, Prizada A, Popadiuk C, et al. (2009) KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma. Br J Cancer 101: 1107-1113.